3379 results for «2026年3月22日易方达纳斯达克100溢价率»
3379 results
Unusual structural interventions: infective endocarditis, ventricular septal rupture & hypertrophic obstructive cardiomyopathy
17 Nov 2025 – From PCR London Valves 2025
This session explores unusual structural interventions, focusing on percutaneous solutions for right-sided infective endocarditis, post-myocardial infarction ventricular septal rupture closure, and novel septal reduction techniques for hypertrophic obstructive cardiomyopathy. It presents challenging cases and device selection considerations in complex structural heart disease.
TAVI Valve-in-Valve: Managing unexpected anatomical challenges
17 Nov 2025 – From PCR London Valves 2025
This session examines valve-in-valve interventions in TAVI, highlighting management of concomitant left main disease, unique case narratives such as "The Highlander story," and the unpredictability inherent in these procedures. It also reviews successful transfemoral TAV-in-SAV interventions in acute heparin-induced thrombocytopenia and addresses treatment of degenerated sutureless...
Featured research - TAVI: cutting-edge developments
17 Nov 2025 – From PCR London Valves 2025
This featured research session reviews cutting-edge developments in TAVI, addressing challenges and outcomes in young patients with bicuspid aortic valve stenosis, prognostic significance of concomitant valvular disease, and long-term results of prophylactic chimney stenting and prosthetic valve performance in bicuspid stenosis.
Paravalvular leak closure - Part 2
17 Nov 2025 – From PCR London Valves 2025
This session is dedicated to paravalvular leak (PVL) closure techniques, featuring percutaneous approaches after surgical valve implantation and TAVI complications such as annulus rupture. It includes advanced management using multiple plugs for long-tunnel mitral PVLs, innovative transformation from pop-up to plug strategies, and transapical approaches following...
Valve interventions in grown-up congenital heart disease
17 Nov 2025 – From PCR London Valves 2025
This session presents complex valve interventions in patients with grown-up congenital heart disease, showcasing innovative transcatheter approaches including combined TAVI and pulmonary valve implantation in high-risk patients. Cases highlight management strategies in elderly patients with concomitant conditions such as patent ductus arteriosus and severe left ventricular...
TAVI complications
17 Nov 2025 – From PCR London Valves 2025
This session delves into the management of complications arising during TAVI procedures, presenting real-world cases such as major vascular events including abdominal aortic dissection and catastrophic iliac artery perforation. It also covers technical solutions for valve embolisation and valve deformation due to calcific aorta, providing valuable...
TAVI for pure aortic regurgitation: different animal, different challenges, different approaches
17 Nov 2025 – From PCR London Valves 2025
This session delves into the unique anatomical and pathophysiological challenges posed by pure aortic regurgitation and their impact on treatment strategies. It reviews clinical outcomes with established and new transcatheter devices, and presents emerging technologies that promise to advance therapeutic options for this distinct patient population.
TAVI in aortic regurgitation - Part 2
17 Nov 2025 – From PCR London Valves 2025
This session focuses on transcatheter aortic valve implantation in the setting of aortic regurgitation, a challenging clinical entity. It features novel techniques such as pump-assisted deployment and the use of deflectable self-expanding systems, as well as management of patients with prior valve-sparing aortic root surgery and...
From diagnosis to device: decision-making and planning for mitral valve interventions
17 Nov 2025 – From PCR London Valves 2025
This session offers a comprehensive overview of decision-making and procedural planning for transcatheter mitral valve interventions. It emphasizes patient-specific factors, advanced imaging for valve morphology assessment, device selection, and the integration of emerging technologies to tailor optimal treatment strategies for mitral valve disease.
Transcatheter mitral valve-in-valve: transcatheter rescue, balloon migration & more
17 Nov 2025 – From PCR London Valves 2025
This session addresses transcatheter mitral valve-in-valve and valve-in-ring interventions in complex clinical contexts. It includes cases of rescue procedures in valvular dysfunction, ECMO-assisted mitral valve-in-ring implantation in severe left ventricular dysfunction, and innovative approaches to mitral ring anatomy challenges, offering practical insights and procedural tips for...
Early Career Research Award Final
17 Nov 2025 – From PCR London Valves 2025
Highlighting pioneering research in structural heart interventions, this session presents studies on the impact of transcatheter tricuspid valve replacement (TTVR) on left ventricular geometry and function, myocardial remodeling in aortic stenosis, physiological responses after mitral and tricuspid edge-to-edge repairs, advancing the understanding of device effects on...
Complex combined interventions - Part 3
17 Nov 2025 – From PCR London Valves 2025
This session highlights complex combined transcatheter interventions, demonstrating simultaneous management of multiple valvular and aortic pathologies. Cases include percutaneous treatment of degenerated bioprosthetic valves, TAVI in rheumatic small annuli with multivalvular disease, and endovascular repair of ascending aortic pseudoaneurysm, illustrating comprehensive strategies for multifaceted cardiovascular disease.
Percutaneous mitral balloon commissurotomy in unusual scenarios
17 Nov 2025 – From PCR London Valves 2025
This session examines percutaneous mitral balloon commissurotomy applied in unusual and challenging scenarios. It covers advanced techniques such as wire-guided Inoue balloon valvuloplasty post annuloplasty, strategies for severe mitral calcification, and innovative simplifications of established methods, emphasizing the ongoing relevance of this procedure in complex mitral...
Paravalvular leaks and VSD percutaneous closure - Recorded cases
17 Nov 2025 – From PCR London Valves 2025
Recorded case 1: A 56-year-old female with a prior mechanical mitral valve replacement (Star GK, 2018), permanent AF, and normal LV function presented with recurrent HF admissions due to paravalvular leaks. She was treated with implantation of multiple plugs via a transseptal approach using a Destination...
Leaflet modification techniques: latest acronyms, concepts and best practice
17 Nov 2025 – From PCR London Valves 2025
Gain comprehensive insights into leaflet modification techniques with a focus on the latest acronyms, concepts, and best practices. This session covers step-by-step approaches to transcatheter electrosurgical leaflet modification, including BASILICA, SHORTCUT, and UNICORN, alongside troubleshooting strategies and the innovative SURPLUS surgical technique.
Unusual structural interventions - Part 2
18 Nov 2025 – From PCR London Valves 2025
This session highlights unusual structural interventions in cardiology, featuring comprehensive CT screening for left atrial appendage closure, management of procedural complications, novel access techniques for balloon aortic valvuloplasty, transcatheter treatment of mitral bioprosthetic valve vegetation, and percutaneous ventricular septal rupture closure success criteria.
Mitral paravalvular leak closure: procedural planning and step-by-step performance
17 Nov 2025 – From PCR London Valves 2025
This session provides an expert overview of mitral paravalvular leak closure, emphasizing critical clinical and anatomical selection criteria. It covers essential pre-procedural imaging and planning strategies, complemented by an educational recorded case and a review of immediate and long-term procedural outcomes.
Featured research - TAVI - Part 12
18 Nov 2025 – From PCR London Valves 2025
This session presents advanced research on transcatheter aortic valve implantation (TAVI), featuring an extensive 30-year in-vitro durability analysis of the Evolut self-expanding valve. It also covers predictive studies on valve-in-valve procedure volumes comparing Japan and the United States, insights into TAVI in patients with left ventricular...
Featured research - TAVI - Part 13
18 Nov 2025 – From PCR London Valves 2025
This session delves into key clinical and procedural advances in TAVI, including the randomized PAF-TAVI trial assessing amiodarone for preventing post-TAVI atrial fibrillation, cost comparisons of balloon-expandable tissue preservation valves versus other devices, leaflet modification methods to reduce coronary obstruction risk, optimization techniques for valve-in-valve TAVI...
Heart Team management of complex valve disease
17 Nov 2025 – From PCR London Valves 2025
Explore the dynamics of managing complex valve disease within a multidisciplinary Heart Team framework. This session discusses strategies for building and sustaining high-functioning teams, integrating multimodality imaging, clinical risk assessment, AI tools, and patient preferences into decision-making, alongside effective communication methods to support collaborative care.
